The more commonly used anti-VEGF drugs in clinical practice include two types, one is razumab injection, and the price of this drug is 5700 yuan a piece. The second is Compazepine injection, and the price of this drug is usually around 5,000 yuan. Both of these drugs belong to anti-VEGF drugs, which can be used for the treatment of fundus neovascular diseases, such as wet age-related macular degeneration, diabetic macular degeneration, or highly myopic macular degeneration, macular edema, and fundus neovascular lesions, all of these diseases can be treated with this drug. The principle of this drug treatment means that the treatment is achieved by inhibiting the formation of neovascularization in the eye and promoting the regression of the neovascularization that has been produced. Therefore, anti-VEGF drugs can be chosen for the treatment of the above mentioned diseases if they exist.